Before having Aquablation (water ablation) therapy, it is essential to check that the treatment, equipment, medical facility, and healthcare professional are Medicare-approved and that the person ...
PROCEPT BioRobotics ® (Nasdaq: PRCT) today highlighted the latest update to the European Association of Urology (EAU) Guidelines for male lower urinary tract symptoms (LUTS), which include an upgrade ...
Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common condition affecting millions of men, especially those over 50. It can lead to uncomfortable urinary symptoms and significantly ...
Two interventions to treat large prostates produced similar symptom relief but had different effects on prostate volume and different adverse event profiles, a large randomized trial showed. Baseline ...
A new treatment for an enlarged prostate is gaining popularity among doctors in Southwest Florida. The innovative procedure offers relief without traditional surgery. James Crumbaugh, a patient who ...
PROCEPT BioRobotics trades at 2.9x forward EV/2026E revenue, a deep discount to peers, despite 27-33% guided revenue growth. Learn why PRCT stock is a buy.
Allegheny Health Network is the first health system in the region to offer Aquablation to treat benign prostatic hyperplasia. More than 40 million American men will be affected by benign prostatic ...
SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (PRCT) ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
THOMASVILLE — Archbold is now offering Aquablation therapy with the new HYDROS™ Robotic System, the next-generation platform to treat men suffering from benign prostatic hyperplasia (BPH). BPH, ...
Spire Southampton Hospital has continued its investment in robotic surgery with the addition of the Aquablation therapy ...
SAN JOSE, Calif., July 23, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...